Cranial Neuropathy as Sign of Systemic Vasculitis: Clinical Case

Authors

  • Dina Neto Serviço de Medicina Interna, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal
  • Rafaela Lopes Freitas Serviço de Medicina Interna, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal
  • Patrícia Rafaela Rodrigues Departamento de Oncologia Médica, Instituto Português de Oncologia Francisco Gentil, Porto, Portugal
  • Isabel Cruz Serviço de Medicina Interna, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal
  • Rui Môço Serviço de Medicina Interna, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal

DOI:

https://doi.org/10.60591/crspmi.75

Keywords:

Nervous System Diseases, Vasculitis

Abstract

Vasculitides are a heterogeneous group of diseases, characterized by inflammation and necrosis of the blood vessel walls. Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is a small vessels vasculitis and include microscopic polyangiitis, granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.

Vasculitides can be life threatening. Immunosuppression is the cornerstone of therapy.

We present the case of a 55-year-old man who in September of 2020 was evaluated in the emergency department for fever, night sweats, myalgia and asthenia. At the same time he had palpable purpura in both legs and inflammatory, symmetrical and migratory arthralgias. He was admitted to an internal medicine ward and during the hospitalization he developed headache, left peripheral facial paralysis, mild bilateral sensorineural hearing loss and horizontal nystagmus. Blood analysis revealed positive proteinase 3 (PR3) ANCA and raised serum inflammatory markers. The diagnosis of PR3-ANCA positive systemic vasculitis with cranial neuropathies involving the VII and VIII pairs was established and he started rituximab and high dose steroids with complete regression of the systemic symptoms and gradual improvement of the cranial neuropathies.

Although uncommon, cranial neuropathy can be the defining manifestation of ANCA-positive vasculitis, as shown in this clinical case.

Downloads

Download data is not yet available.

References

Jatwani S, Goyal A. Vasculitis. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2023.

Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990;33:1065-7. doi: 10.1002/art.1780330802.

Fries JF, Hunder GG, Bloch DA, Michel BA, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33:1135-6. doi: 10.1002/art.1780330812.

Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17:603-6. doi: 10.1007/s10157-013-0869-6.

Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis. Ann Rheum Dis. 2022;81:309-14. doi: 10.1136/annrheumdis-2021-221794.

Craven A, Robson J, Ponte C, Grayson PC, Suppiah R, Judge A, et al. ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). Clin Exp Nephrol. 2013;17:619-21. doi: 10.1007/s10157-013-0854-0.

Ponte C, Khmelinskii N, Teixeira V, Luz K, Peixoto D, Rodrigues M, et al. Reuma.pt/vasculitis - the Portuguese vasculitis registry. Orphanet J Rare Dis. 2020;15:110. doi: 10.1186/s13023-020-01381-0.

Khmelinskii N, Seixas MI, Ponte C, Fonseca JE, Macieira C. The Added Value of a Vasculitis Clinic in a Tertiary Referral Hospital. Acta Med Port. 2018;31:614-7. doi: 10.20344/amp.9875.

Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6:71. doi:

1038/s41572-020-0204-y.

Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997;40:371-80. doi: 10.1002/art.1780400222.

Berti A, Cornec D, Crowson CS, Specks U, Matteson EL. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study. Arthritis Rheumatol. 2017;69:2338-50. doi: 10.1002/art.40313.

Choi HA, Lee MJ, Chung CS. Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis. J Neurol. 2017;264:724-32. doi: 10.1007/s00415-017-8416-0.

Koike H, Nishi R, Ohyama K, Morozumi S, Kawagashira Y, Furukawa S, et al. ANCA-Associated Vasculitic Neuropathies: A Review. Neurol Ther. 2022;11:21-38. doi: 10.1007/s40120-021-00315-7.

Graf J, Imboden J. Vasculitis and peripheral neuropathy. Curr Opin Rheumatol. 2019;31:40-5. doi: 10.1097/BOR.0000000000000559.

Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75:1583-94. doi: 10.1136/annrheumdis-2016-209133.

Published

15-09-2023

How to Cite

Neto, D., Lopes Freitas, R., Rodrigues, P. R., Cruz, I., & Môço, R. (2023). Cranial Neuropathy as Sign of Systemic Vasculitis: Clinical Case. SPMI Case Reports, 1(3), 134–138. https://doi.org/10.60591/crspmi.75

Most read articles by the same author(s)